MatriksBiotek品牌產(chǎn)品列表介紹

供應(yīng)數(shù)量：1119
原產(chǎn) 地：
發(fā)布日期：2025/8/23
已獲點擊：1119

詳細(xì)資料

MatriksBiotek品牌產(chǎn)品列表介紹

MatrikSBIotek®Co。，作為一家成立于2002年的生物技術(shù)公司，正在慶祝其15年的業(yè)務(wù)。以生產(chǎn)為導(dǎo)向的公司致力于研究和創(chuàng)新免疫，分子和工具，將有助于健康。在市場上使用生物藥物測試SHIKARI®ELISA試劑盒，自從在市場上*生產(chǎn)和商業(yè)化以來已有10年的歷史。

在36個國家和30多家制藥公司充滿信心地使用和/或使用我們的產(chǎn)品。生物制劑（主要是人源化重組單克隆抗體）在某些疾病中作為藥物的使用引起每個單獨治療的人的有效性問題。監(jiān)測藥物水平和抗體在管理對重組和/或人源化抗體的反應(yīng)缺乏或喪失方面發(fā)揮著新的作用（即，確認(rèn)治療持續(xù)，劑量調(diào)整，提供轉(zhuǎn)換為另一種藥劑或不同藥劑的理由一類生物制劑）。

MatriksBiotek品牌產(chǎn)品列表介紹

MatrikSBIotek介紹

Reference Code	Product Name	Description
TR-Q-INFLIXIv2	Q-INFLIXI	Enzyme immunoassay for the quantitative determination of free Infliximab (Remicade®) in serum and plasma
TR-ATIv5	Q-ATI	Enzyme immunoassay for the qualitative determination of specific antibodies to infliximab in human serum and plasma with confirmation
TR-ATIv6	Q-ATI	Enzyme immunoassay for the quantitative determination of specific antibodies to infliximab in human serum and plasma with confirmation
TR-ATIv8	Q-ATI DUO	Enzyme immunoassay for the semi-quantitative determination (screening) of total and free antibodies to infliximab (Remicade®) in serum and plasma.
TR-ADAv1	Q-ADA	Enzyme immunoassay for the quantitative determination of free adalimumab (Humira®) in serum and plasma
TR-AADAv1	S-ATA	Enzyme immunoassay for the qualitative determination of antibodies to adalimumab (Humira®) in serum and plasma with confirmation
TR-AADAv2	S-ATA	Enzyme immunoassay for the quantitative determination of antibodies to adalimumab (Humira®) in serum and plasma with confirmation
TR-AADAv4	S-ATA DUO	Enzyme immunoassay for the semi-quantitative determination (screening) of total and free antibodies to adalimumab (Humira®) in serum and plasma
TR-ETAv2	Q-ETA	Enzyme immunoassay for the quantitative determination of free Etanercept (Enbrel) in serum and plasma
TR-AETAv2	S-ATE	Enzyme immunoassay for the qualitative determination of antibodies to etanercept in serum and plasma
TR-BEVAv2	Q-BEVA	Enzyme immunoassay for the quantitative determination of Bevacizumab (Avastin®) in serum and plasma
TR-ABEVAv1	S-ATB	Enzyme immunoassay for the qualitative determination of antibodies to Bevacizumab (Avastin®) in serum and plasma
TR-ABEVAv2	S-ATB	Enzyme immunoassay for the quantitative determination of antibodies to Bevacizumab (Avastin®) in serum and plasma
TR-RTXv2	Q-RITUX	Enzyme immunoassay for the quantitative determination of antibodies to Rituximab® (Rituxan®, Mabthera®) in serum and plasma
TR-ARTXv1	S-ATR	Enzyme immunoassay for the qualitative determination of antibodies to Rituximab® (Rituxan®, Mabthera®) in serum and plasma
TR-ARTXv2	S-ATR	Enzyme immunoassay for the quantitative determination of antibodies to Rituximab® (Rituxan®, Mabthera®) in serum and plasma
TR-TRASv2	Q-TRAS	Enzyme immunoassay for the quantitative determination of Trastuzumab (Herceptin®, Herclon®)
TR-ATRASv1	S-ATT	Enzyme immunoassay for the qualitative determination of antibodies to Trastuzumab (Herceptin®, Herclon®) in serum and plasma
TR-ATRASv2	S-ATT	Enzyme immunoassay for the quantitative determination of antibodies to Trastuzumab (Herceptin®, Herclon®) in serum and plasma
TR-GOLv1	Q-GOL	Enzyme immunoassay for the quantitative determination of free Golimumab (Simponi®) in serum and plasma.
TR-ATGv1	S-ATG	Enzyme immunoassay for the qualitative determination of antibodies to Golimumab in serum and plasma.
TR-CETv1	Q-CET	Enzyme immunoassay for the quantitative determination of free Cetuximab (Erbitux®) in serum and plasma.
TR-ATCv1	S-ATC	Enzyme immunoassay for the qualitative determination of antibodies to cetuximab in serum and plasma.
TR-ATCv2	S-ATC	Enzyme immunoassay for the quantitative determination of antibodies to cetuximab in serum and plasma.
TR-REMSv1	Q-REMS	Enzyme immunoassay for the quantitative determination of free Infliximab (Remsima®) in serum and plasma.
TR-AREMSv1	S-AIR	Enzyme immunoassay for the qualitative determination of antibodies to Infliximab Remsima in serum and plasma.
TR-AREMSv2	S-AIR	Enzyme immunoassay for the quantitative determination of antibodies to Infliximab Remsima in serum and plasma.
TR-AREMSv3	S-AIR	Enzyme immunoassay for the semi-quantitative determination (screening) of total antibodies to Infliximab biosimilar (Remsima®) in serum and plasma.
TR-QDENv1	Q-DEN	Enzyme immunoassay for the quantitative determination of Denosumab (Prolia®)in serum and plasma.
TR-AATDv1	S-ATD	Enzyme immunoassay for the qualitative determination of antibodies to Denosumab in serum and plasma.
TR-OMAv1	Q-OMA	Enzyme immunoassay for the quantitative determination of Omalizumab (Xolair®) Remsima in serum and plasma.
TR-AATOv1	S-ATO	Enzyme immunoassay for the qualitative determination of antibodies to Omalizumab in serum and plasma.
TR-Q-NIVOv1	Q-NIVO	Enzyme immunoassay for the quantitative determination of Nivolumab (Opdivo®) in serum and plasma.
TR-ATNv1	S-ATN	Enzyme immunoassay for the qualitative determination of antibodies to Nivolumab in serum and plasma.
TR-PEMv1	Q-PEM	Enzyme immunoassay for the quantitative determination of Pembrolizumab (Keytruda®) in serum and plasma.
TR-A-PEMv1	S-ATP	Enzyme immunoassay for the qualitative determination of antibodies to Pembrolizumab in serum and plasma.
TR-AFAv1	Q-AFA	Enzyme immunoassay for the quantitative determination of specific anibodies to Filgrastim in serum and plasma.
TR-IPIv1	Q-IPI	Enzyme immunoassay for the quantitative determination of specific Ipilimumab(Yervoy®) in human serum and plasma.
TR-AIPIv1	S-ATI	Enzyme immunoassay for the qualitative determination of specific anibodies to Ipilimumab in serum and plasma.
TR-Q-AVEv1	Q-AVE	Enzyme immunoassay for the quantitative determination of specific Avelumab(Bavencio®) in human serum and plasma.
TR-A-AVEv1	S-ATAV	Enzyme immunoassay for the qualitative determination of specific anibodies to Avelumab in serum and plasma.
TR-RANv1	Q-RAN	Enzyme immunoassay for the quantitative determination of free Ranibizumab in aqueous humour.
TR-RAMv1	Q-RAM	Enzyme immunoassay for the quantitative determination of free Ramucirumab in serum and plasma.
TR-ARAMv1	S-ATRAM	Enzyme immunoassay for the qualitative determination of antibodies to Ramucirumab in serum and plasma.
TR-CERTv2	Q-CERT	Enzyme immunoassay for the quantitative determination of Certolizumab in human serum and plasma
TR-Q-VEDOv1	Q-VEDO	Enzyme immunoassay for the quantitative determination of Vedolizumab in human serum and plasma
TR-ATVv1	S-ATV	Enzyme immunoassay for the qualitative determination of antibodies to Vedolizumab in human serum and plasma
TR-Q-USTv1	Q-UST	Enzyme immunoassay for the quantitative determination of Ustekinumab in human serum and plasma
TR-AUSTv1	S-ATU	Enzyme immunoassay for the qualitative determination of antibodies to Ustekinumab in human serum and plasma

如果你對MatriksBiotek品牌產(chǎn)品列表介紹感興趣，想了解更詳細(xì)的產(chǎn)品信息，填寫下表直接與廠家聯(lián)系：

留言框

產(chǎn)品：
您的單位：
您的姓名：
聯(lián)系電話：
常用郵箱：
省份：
詳細(xì)地址：
補充說明：
驗證碼：

請輸入計算結(jié)果（填寫阿拉伯?dāng)?shù)字），如：三加四=7

MatriksBiotek品牌產(chǎn)品列表介紹

留言框

產(chǎn)品：

您的單位：

您的姓名：

聯(lián)系電話：

常用郵箱：

省份：

詳細(xì)地址：

補充說明：

驗證碼：